| Net earnings | |
| (Earnings)/loss from discontinued operations | |
| Earnings from continuing operations | |
| Depreciation and amortization | |
| Loss on extinguishment of debt | |
| Gain on sale of investment in CareFusion | |
| Impairments and loss on sale of assets | |
| Share-based compensation | 23M |
| Provision for deferred income taxes | |
| Provision for bad debts | 7M |
| Decrease/(increase) in trade receivables | -306M |
| Decrease/(increase) in inventories | -298M |
| Increase/(decrease) in accounts payable | 279M |
| Other accrued liabilities and operating items, net | -87M |
| Net cash provided by operating activities-continuing operations | |
| Net cash provided by/(used in) operating activities-discontinued operations | |
| Net cash provided by operating activities | 104M |
| Proceeds from divestitures and sale of property and equipment | |
| Acquisition of subsidiaries, net of cash acquired | -9M |
| Purchase of held-to-maturity investment securities | |
| Additions to property and equipment | -100M |
| Proceeds from sale of CareFusion common stock | |
| Proceeds from maturities of held-to-maturity securities | |
| Net cash provided by/(used in) investing activities-continuing operations | |
| Net cash used in investing activities-discontinued operations | |
| Net cash provided by/(used in) investing activities | -110M |
| Payment of contingent consideration | 0 |
| Net change in short-term borrowings | |
| Reduction of long-term obligations | -1M |
| Proceeds from long-term obligations, net of issuance costs | |
| Proceeds from issuance of Common Shares | |
| Tax disbursements from exercises of stock options | 30M |
| Payment of premiums for debt extinguishment | |
| Dividends on Common Shares | -149M |
| Purchase of treasury shares | -250M |
| Net cash used in financing activities-continuing operations | |
| Net cash provided by/(used in) financing activities-discontinued operations | |
| Net cash used in financing activities | -350M |
| NET INCREASE/(DECREASE) IN CASH AND EQUIVALENTS | -355M |
| CASH AND EQUIVALENTS AT BEGINNING OF YEAR | 2.36B |
| CASH AND EQUIVALENTS AT END OF YEAR | 2B |
| Interest | |
| Income taxes | |
| Retained investment in CareFusion at date of Spin-Off | |
| Non-cash dividend in connection with Spin-Off | |